Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1171)	2/13/1999 2:37:00 AM
From: erin4	Read Replies (3) \| Respond to of 2539

I have a sizeable stake in Monsanto. The Celebrex story is very positive but the agriculture side seems like a millstone. MTC financially is not as strong as many of the big pharmaceutical companies. Merks competitive drug Viox may be in the market in 4-5 months. A potential positive would be a buyout of MTC by a larger company,eg, Dupont but this may not happen. I am thinking that a better way to play the Celebrex story is thru Pfizer which is a much stronger company financially and a company with a better pipeline of pending drugs.